Activated Charcoal Araneus Diadematus Artemisia Ci
| Evidence Level: L5 | Predicted Indications: 0 |
Table of Contents
- Activated Charcoal Araneus Diadematus Artemisia Ci
- Multi-Component Homeopathic Formula: Insufficient Data to Complete Drug Repurposing Assessment
Multi-Component Homeopathic Formula: Insufficient Data to Complete Drug Repurposing Assessment
One-Sentence Summary
This product is a homeopathic formula containing 23 components comprising plant extracts, microbial nosodes, and metabolites. As the TxGNN system could not match any DrugBank records, no new indication predictions can be generated at present, nor is there clinical trial or literature support for the repurposing direction of this formula as a whole.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | No record (not listed in any approved database) |
| Predicted New Indication | None (TxGNN generated no prediction) |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model unable to assess; lack of any actual research) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
This product comprises the following 23 components of highly heterogeneous nature:
| Category | Components |
|---|---|
| Homeopathic Carbon Remedies | Activated Charcoal, Carbo Animalis |
| Plant Extracts | Artemisia Cina, Berberis Vulgaris Root Bark, Frangula Purshiana Bark, Medicago Sativa, Podophyllum, Rheum Palmatum Root, Spigelia Anthelmia, Taraxacum Officinale, Veratrum Album Root |
| Microbial Nosode | Proteus Mirabilis, Salmonella Enterica Enterica Serovar Enteritidis |
| Animal-derived | Araneus Diadematus (spider), Heparin Bovine, Sus Scrofa Intestinal Mucosa |
| Metabolites/Elements | Bilirubin, Creatine, Creatinine, Indole, Selenium, Skatole |
| Mineral Homeopathic Remedies | Mercurius Solubilis |
Based on the component composition, this product appears to be a bowel nosode homeopathic formula, traditionally used for intestinal function modulation. However:
- DrugBank does not maintain this formula as a whole nor provide a DrugBank ID, preventing TxGNN’s knowledge graph from performing node matching.
- Most components in the formula are homeopathic-specific preparations whose active ingredients are diluted to such extreme degrees that they fall outside the scope of modern pharmacological databases.
- Mechanism of action (MOA) data are entirely absent, precluding mechanism-based association analysis.
Conclusion: It is technically infeasible to perform drug repurposing prediction on this formula in its current form; component standardization and data completion are prerequisites.
Clinical Trial Evidence
No relevant clinical trial records are currently available.
Literature Evidence
No relevant literature is available for retrieval at present.
US Market Information
This product has no approved marketing authorization (NDA) in the United States (Number of NDAs: 0).
Safety Considerations
Please refer to the warnings and contraindications in the product’s package insert.
Caution: This formula contains the following components requiring special attention:
- Mercurius Solubilis (mercury compound homeopathic remedy): Mercury at high doses exhibits neurotoxicity; risk assessment after homeopathic dilution requires individual evaluation
- Heparin, Bovine (bovine heparin): theoretically possesses anticoagulant activity; concurrent use with anticoagulant drugs requires caution
- Veratrum Album (false hellebore): plant alkaloid content carries potential toxicity
- Podophyllum (podophyllum): contains podophyllotoxin with cytotoxic potential
Conclusion and Next Steps
Decision: Hold
Rationale: This formula, owing to its highly complex composition and special homeopathic category status, cannot be recognized by the TxGNN model to identify its DrugBank-corresponding node, resulting in complete inability to generate prediction results; in the absence of any predictions, clinical trials, or literature support, advancement of drug repurposing assessment is not recommended.
To proceed, the following is needed:
- Component-by-component evaluation: Query each of the 23 components individually against DrugBank to screen for those with pharmacological records (e.g., berberine from Berberis Vulgaris, emodin from Rheum Palmatum), and perform TxGNN prediction separately for these single-component entities
- Principal component confirmation: Clarify which “therapeutic principal component(s)” this formula addresses, excluding pure homeopathic diluted components (e.g., Mercurius Solubilis, nosode category), and focus on components with substantive pharmacological significance
- Indication definition: Supplement the formula’s original approved indication or traditional use record as the starting point for drug repurposing
- MOA data completion: For each plant component, query the DrugBank API or PubChem to supplement mechanism of action data
- Safety data completion: Download package inserts or toxicological data for each component to complete the warnings/contraindications assessment required by S1 safety initial review
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.